V
Vertos Medical
And markets medical devices that are used for the treatment of common spinal diseases
About Vertos Medical
Vertos Medical Inc. is a pioneering medical device company specializing in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS). The company's flagship product, the mild procedure, offers a safe, outpatient, fluoroscopically guided therapeutic treatment for LSS that requires no general anesthesia, no implants, and no stitches. This procedure is designed to alleviate symptoms such as pain and numbness in the lower back and legs, which are commonly associated with the degenerative narrowing of the lower spinal canal.
Vertos Medical primarily serves patients suffering from LSS, providing them with a less invasive alternative to traditional surgical methods. The company operates in the medical device market, focusing on interventional pain procedures and lumbar spine treatments. Its business model revolves around the development, manufacturing, and distribution of its proprietary mild device kit, which has received CE mark approval for use in Europe.
Revenue is generated through the sale of these medical devices to healthcare providers and clinics that specialize in spinal treatments. By offering a procedure that can be performed on an outpatient basis, Vertos Medical aims to reduce the overall healthcare costs and improve the quality of life for patients with LSS.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2005
- Headquarters
- Aliso Viejo, United States
- Employees
- 38
- Open positions
- None listed
- Dealroom signal
- 60.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Aug 2024 | $0 | — | Stryker | ↗ |
| SERIES COther financing | Jun 2023 | $26M | $140M | Pitango Venture Capital · Norwest Venture Partners | ↗ |
Growth signals
Latest recorded traffic for Vertos Medical is 110 monthly website visits, down 99.3% over the last three months. Vertos Medical's team declined 83.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Mercury Fund
Series B and later10 investors entered at this stage
Foundation Capital
CHL Medical Partners- OVOnset Ventures
- FPFoundation Medical Partners
Aweida Venture Partners
Pitango Venture Capital
MVM Life Science Partners
Revelation Partners
Transformation Capital
Norwest Venture Partners
Other known investors1 additional known investor
Stryker
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vertos Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vertos Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.